Substance Abuse Treatment Market Summary

The global substance abuse treatment market size was estimated at USD 10.25 billion in 2022 and is projected to reach USD 20.51 billion by 2030, growing at a CAGR of 9.05% from 2023 to 2030. The industry is witnessing significant growth due to factors such as rising awareness about available treatment options and the increasing prevalence of substance abuse disorders. Growing public concern over drug and alcohol addiction, coupled with improved healthcare infrastructure, has led to a higher demand for treatment facilities and rehabilitation centers. In addition, technological advancements in treatment methods, such as telemedicine and digital therapy platforms, are improving access to care, especially in remote areas.

Moreover, supportive government initiatives, including drug awareness campaigns, community-based prevention programs, and favorable reimbursement policies, are expected to propel industry growth over the forecast period. Substance abuse encompasses the misuse of illegal drugs, prescription medications, or alcohol for purposes other than those medically intended or in excessive quantities, often leading to severe physical and psychological dependence. Rising mental health issues and lifestyle stressors have also contributed to the growing number of individuals seeking rehabilitation and detoxification treatments globally.

Key Market Trends & Insights

  • North America dominated the industry in 2022 and accounted for the largest share of more than 33.65% of the overall revenue. This dominance is attributed to the presence of advanced healthcare infrastructure, higher awareness about treatment programs, and a growing number of rehabilitation centers across the region. Government and private sector efforts to curb opioid addiction, alongside increased funding for substance abuse prevention, have further strengthened the regional market.
  • By treatment type, the tobacco/nicotine and vaping segment held the largest share of more than 33.30% of the overall revenue in 2022. The increasing number of smokers and the growing popularity of vaping products, especially among young adults, have resulted in higher demand for cessation therapies, behavioral counseling, and pharmacological treatments. Continuous research and product innovation are enhancing treatment outcomes and patient adherence rates.
  • By end use, the hospital end-use segment dominated the industry in 2022 and accounted for the largest share of 37.83% of the total revenue. Hospitals serve as primary centers for detoxification and intensive care, offering specialized programs for withdrawal management and recovery. The increasing number of hospital-based rehabilitation programs and integration of mental health services have further driven this segment’s growth.

Order a free sample PDF of the Substance Abuse Treatment Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

  • 2022 Market Size: USD 10.25 Billion
  • 2030 Projected Market Size: USD 20.51 Billion
  • CAGR (2023-2030): 9.05%
  • North America: Largest market in 2022

Key Companies & Market Share Insights

The key players operating are constantly focusing on changing existing technologies and introducing new ones that enhance patient outcomes and significantly increase the effectiveness & efficiency of healthcare. For instance, in February 2023, Jovive Health launched Medication-Assisted Treatment (MAT) to help diminish the effects of dependence on opioids for patients with Opioid Use Disorders (OUD). 

Key Players

  • Teva Pharmaceutical Industries Ltd.
  • Abbott
  • GSK plc.
  • Cipla Inc.
  • Lilly (Eli Lilly and Company)
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Reddy’s Laboratories Ltd.
  • Viatris Inc.
  • AstraZeneca

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The substance abuse treatment market is poised for robust growth, driven by rising addiction rates, expanding awareness campaigns, and supportive healthcare policies. Increasing integration of mental health care with substance abuse treatment, along with the use of digital therapy tools, is expected to enhance accessibility and treatment efficiency. While North America continues to lead, emerging markets in Asia-Pacific and Europe are showing promising growth due to improving healthcare infrastructure and evolving social attitudes toward addiction. Continuous innovation in treatment methods, government intervention, and public-private collaboration will remain crucial in shaping the future of the global substance abuse treatment industry.